The medical technology industry’s R&D investments are in decline, consulting firm EY says in a new report.
Category: NYSE:JNJ
Opioid Lawsuits Looking More Like A Tobacco Settlement Every Day
Drug makers, PBMs and drugstore chains involved in the sale and distribution of opioids may have reason to fear “a tobacco-style master settlement agreement,” Fitch Ratings says.
New Documentary Film Is Scathing Indictment Of FDA’s Regulation Of Medical Devices
A new documentary film highlights multiple systemic flaws in the FDA’s approval process specifically for medical devices and it’s putting millions of patients at risk.
Earnings Preview: What To Expect From Intuitive Surgical On Thursday
Intuitive Surgical is expected to report $2.50/share on $868.48 million in revenue. Meanwhile, the so-called Whisper number is $2.65.
Did Pfizer Blink And What Will Pharma Do Now?
Pfizer confirmed that time has run out for raising prices without blow-back. The renewed attention to drug price hikes means business as usual has ended and two questions loom large for Pharma. Is talk of regulation of drug prices next and who will ne…
If You Look For Atrial Fibrillation You Will Find Atrial Fibrillation
If you look hard to find people who have atrial fibrillation you will find atrial fibrillation. But a new study offers no evidence whatsoever that the new diagnosis improves outcomes, though it does find that the diagnosis leads to increased use of dru…
Big Pharma Rises To The Ebola Challenge
“If you have technology that can help fight the most deadly virus in the world, you can’t stand back and not do this.”
Pharma R&D Investments Moderating, But Still High
However, it is clear that the pharmaceutical industry is going to continue to invest in R&D at a pretty healthy rate for the foreseeable future.
- 1
- 2
